Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Metotrexato para la inducción de la remisión en la enfermedad de Crohn refractaria

Esta versión no es la más reciente

ver la versión actual 06 agosto 2014

Información

DOI:
https://doi.org/10.1002/14651858.CD003459.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 diciembre 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Salud digestiva

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • John WD McDonald

    Correspondencia a: Robarts Clinical Trials, Robarts Research Institute, London, Canada

    [email protected]

  • David J Tsoulis

    Robarts Clinical Trials, Robarts Research Institute, London, Canada

  • John K MacDonald

    Robarts Clinical Trials, Robarts Research Institute, London, Canada

  • Brian G Feagan

    Robarts Clinical Trials, Robarts Research Institute, London, Canada

Declarations of interest

Brian Feagan and John McDonald are authors of a manuscript that was included in this review. Brian Feagan has received lecture fee(s) from: GlaxoSmithKline, Procter & Gamble Pharmaceuticals, Salix Pharmaceuticals Inc, Shire Pharmaceuticals Inc, Tillotts Pharma AG and Merck. John MacDonald has served as a consultant for Tillotts Pharma AG. All of these financial activities are outside the submitted work. The other authors have no known declarations of interest.

Acknowledgements

Funding for the IBD/FBD Review Group (September 1, 2010 ‐ August 31, 2015) has been provided by the Canadian Institutes of Health Research (CIHR) Knowledge Translation Branch (CON ‐ 105145) and the CIHR Institutes of Nutrition, Metabolism and Diabetes (INMD); and Infection and Immunity (III) and the Ontario Ministry of Health and Long Term Care (HLTC3968FL‐2010‐2235).

Miss Ila Stewart has provided support for the IBD/FBD Review Group through the Olive Stewart Fund.

Version history

Published

Title

Stage

Authors

Version

2014 Aug 06

Methotrexate for induction of remission in refractory Crohn's disease

Review

John WD McDonald, Yongjun Wang, David J Tsoulis, John K MacDonald, Brian G Feagan

https://doi.org/10.1002/14651858.CD003459.pub4

2012 Dec 12

Methotrexate for induction of remission in refractory Crohn's disease

Review

John WD McDonald, David J Tsoulis, John K MacDonald, Brian G Feagan

https://doi.org/10.1002/14651858.CD003459.pub3

2004 Oct 18

Methotrexate for induction of remission in refractory Crohn's disease

Review

Ahmad AF Alfadhli, John WD McDonald, Brian G Feagan

https://doi.org/10.1002/14651858.CD003459.pub2

2002 Oct 21

Methotrexate for induction of remission in Crohn's disease

Protocol

A AF Alfadhli, John W McDonald, B G Feagan

https://doi.org/10.1002/14651858.CD003459

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.